q32bio.com (QTTB) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The biotechnology company develops innovative antibodies to combat autoimmune pathologies in US laboratories, leveraging collaborations with scientific centers. Q32 Bio Inc. (QTTB) aims to expand Phase I/II clinical trials to secure future dominance in the immunoregulation sector. This financial chart on GURU.Markets shows an EV/EBITDA of -0.28, while the company's single-product profile is partially offset by alliances with global pharma behemoths.
q32bio.com - analytical breakdowns and key metrics (QTTB)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
QTTB - Final Profit|Projected Future Earnings Q32 Bio Inc.|QTTB - Price to Earnings Ratio|Forward P/E Multiple Q32 Bio|QTTB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Q32 Bio Inc.|QTTB - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Q32 Bio|QTTB - Earnings per share for the trailing year|Quarterly EPS earnings growth q32bio.com|QTTB - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Q32 Bio Inc.
Initial company analysis:QTTB (Q32 Bio Corp)
The EV/EBITDA multiple determines the business value relative to its operating profit before depreciation, taxes, and interest, allowing for an assessment of debt coverage efficiency. Analyzing the EV/EBITDA fluctuations of Q32 Bio Inc. (QTTB), an investor observes the specifics of the biotechnology sector: the absence of commercial sales and rising clinical trial costs render this indicator extremely volatile.
Main competitors
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|VERA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Multiple Dianthus Corp (DNTH)|PHVS (Pharvaris N.V.) - Enterprise Value to EBITDA Ratio|ABCL (AbCellera) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio TRML|PGEN: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple PHAR|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NKTR (Nektar Corp)|EV/EBITDA Multiple UPB (Upstream Bio Inc)|Total Company Value to Operating Income Before Depreciation Ratio zenasbio.com (ZBIO)|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Enterprise Value to EBITDA Ratio|Septerna Pharma - Business Value to Operating Income Before Depreciation|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|savarapharma.com (SVRA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rigel Pharmaceuticals, Inc. (RIGL)|AnaptysBio Inc - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATXS (Astria Pharma)|ENGN - Enterprise Value to EBITDA Ratio|RAPT: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics, Inc. (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Multiple Kyverna Therapeutics Inc. KYTX|Enterprise Value to EBITDA Ratio TLSA|CABA (Cabaletta Bio Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio VTYX (Ventyx Biosciences)|Enterprise Value to Operating Income Before Depreciation Ratio THTX|EV/EBITDA Multiple AVTX (Avalo Therapeutics)|Eledon Pharmaceuticals Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AGEN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio CLYM|ZURA: EV/EBITDA Multiple|atyrpharma.com - Business Value to Operating Income Before Depreciation|ADAG (Adagene Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple Ikena Oncology, Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Shattuck Labs, Inc. (STTK)|EQ (equilliumbio.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Connect Biopharma Holdings Limited CNTB|IMUX - Enterprise Value to EBITDA Ratio|Atara Biotherapeutics Inc - EV/EBITDA Multiple|IFRX - EV/EBITDA Multiple|XFOR (X4 Pharma) - Enterprise Value to EBITDA Ratio|Adicet Bio, Inc. - Business Value to Operating Income Before Depreciation|CELU (Celularity Inc) - EV/EBITDA Multiple|inmunebio.com (INMB) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Barinthus Biotherapeutics plc (BRNS)|Enterprise Value to EBITDA Ratio Kezar Life Sciences Inc. KZR|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SAB Biotherapeutics, Inc SABS|AKTX - Enterprise Value to EBITDA Ratio|ENLV: Enterprise Value to EBITDA Ratio|GOVX - EV/EBITDA Multiple|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation IBIO|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|Company Value to EBITDA XTL Bio XTLB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|hcwbiologics.com (HCWB) - Enterprise Value to EBITDA Multiple|Aptevo Therapeutics Inc. - Enterprise Value to EBITDA Ratio|aimimmuno.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ADTX: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GRI (GRI Bio Corporation)|XRTX: EV/EBITDA Multiple|HIND (reshapelifesciences.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Indaptus Therapeutics Inc (INDP) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|CALI - Company Value to EBITDA|Affimed N.V. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ALLK|HOOKIPA - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IGM Biosciences, Inc. IGMS|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation OCEA|TCBP (TC Biopharm) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio thirdharmonicbio.com (THRD)
